Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer modelKetil André Camilio, Gunhild M. Mælandsmo|Breast Cancer Research|2019Cited by 65
LTX-315 and adoptive cell therapy using tumor-infiltrating lymphocytes generate tumor specific T cells in patients with metastatic soft tissue sarcomaMorten Nielsen, Inge Marie Svane, Vibeke Sundvold et al.|OncoImmunology|2023Cited by 40